DrugPatentWatch Database Preview

SUSTOL Drug Profile

« Back to Dashboard

When do Sustol patents expire, and when can generic versions of Sustol launch?

Sustol is a drug marketed by Heron Theraps Inc and is included in one NDA. There are six patents protecting this drug.

This drug has sixteen patent family members in ten countries.

The generic ingredient in SUSTOL is granisetron. There are twenty-six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the granisetron profile page.

Summary for SUSTOL

International Patents:	16
US Patents:	6
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	32
Patent Applications:	4,101
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for SUSTOL
DailyMed Link:	SUSTOL at DailyMed

Pharmacology for SUSTOL

Drug Class	Serotonin-3 Receptor Antagonist
Mechanism of Action	Serotonin 3 Receptor Antagonists

Medical Subject Heading (MeSH) Categories for SUSTOL

Antiemetics

Serotonin Antagonists

Synonyms for SUSTOL

1-Methyl-1H-indazole-3-carboxylic acid (9-methyl-9-aza-bicyclo[3.3.1]non-3-yl)-amide

1-METHYL-N-((1R,3R,5S)-9-METHYL-9-AZABICYCLO[3.3.1]NONAN-3-YL)-1H-INDAZOLE-3-CARBOXAMIDE

1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-indazole-3-carboxamide

1-Methyl-N-(9-methyl-endo-9-azabicyclo(3.3.1)non-3-yl)-1H-indazole-3-carboxamide

1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]-3-indazolecarboxamide

1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide

1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-7-yl]indazole-3-carboxamide

1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide

107007-99-8 (mono-hydrochloride)

109889-09-0

121061-98-1

124998-65-8

1H-Indazole-3-carboxamide, 1-methyl-N-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-, endo-

1H-INDAZOLE-3-CARBOXAMIDE, 1-METHYL-N-[(3-ENDO)-9-METHYL-9-AZABICYCLO[3.3.1]NON-3-YL]-

3702AH

889g090

A802101

AB00918713-07

AB07494

AC-8910

AC1NR4P1

AKOS025402424

AN-7538

APF 530

APF530

API0005490

BDBM50443668

BDBM50449636

BIDD:GT0272

BRL 43694

BRL 43964

BRL-43694

C07023

CCG-221158

CHEBI:5537

CHEBI:94501

CHEMBL1290003

D04370

D0J5KF

DB00889

DL-166

DTXSID0023111

ENDO-GRANISETRON

FT-0626805

GRANESETRON

granisetron

Granisetron (JAN/USAN/INN)

Granisetron (USAN/INN)

Granisetron [USAN:INN:BAN:JAN]

Granisetron Monohydrochloride

Granisetronum

GTPL2300

HMS2089P14

Kevatril

Kevatril|||1-Methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide,

Kytril (TN)

Q-101870

Sancuso

Sancuso (TN)

SCHEMBL34178

SCHEMBL4890

SCHEMBL4891

UNII-WZG3J2MCOL

VA11035

W-5139

WZG3J2MCOL

ZINC100018852

ZINC100018854

ZINC347

US Patents and Regulatory Information for SUSTOL

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Heron Theraps Inc	SUSTOL	granisetron	INJECTION, EXTENDED RELEASE;SUBCUTANEOUS	022445-001	Aug 9, 2016		RX	Yes	Yes
Heron Theraps Inc	SUSTOL	granisetron	INJECTION, EXTENDED RELEASE;SUBCUTANEOUS	022445-001	Aug 9, 2016		RX	Yes	Yes
Heron Theraps Inc	SUSTOL	granisetron	INJECTION, EXTENDED RELEASE;SUBCUTANEOUS	022445-001	Aug 9, 2016		RX	Yes	Yes			Y
Heron Theraps Inc	SUSTOL	granisetron	INJECTION, EXTENDED RELEASE;SUBCUTANEOUS	022445-001	Aug 9, 2016		RX	Yes	Yes
Heron Theraps Inc	SUSTOL	granisetron	INJECTION, EXTENDED RELEASE;SUBCUTANEOUS	022445-001	Aug 9, 2016		RX	Yes	Yes			Y

International Patents for SUSTOL

Country	Document Number	Estimated Expiration
China	101052376
Taiwan	200616650
Japan	2012107064
Australia	2005289425
Taiwan	I407966